Increasing evidence for and regulation of a human placental endogenous digitalis-like factor

Reproductive Sciences

Volumn 19, Issue 4, 2012, Pages 437-448

  Ma, Jie ^a   Esplin, M Sean ^b   Adair, C David ^c   Mason, Lorrie A ^c   Graves, Steven W ^a  

^a Brigham Young University   (United States)

^b UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF TENNESSEE AT CHATTANOOGA   (United States)

Author keywords

17 OH progesterone; Digibind; digitalis like factors; hypoxia; ketoconazole; placenta; reactive oxygen species; tumor necrosis factor alpha

Indexed keywords

CYTOKINE; DIGITALIS LIKE FACTOR; DIGOXIN ANTIBODY F(AB) FRAGMENT; HYDROXYPROGESTERONE; KETOCONAZOLE; REACTIVE OXYGEN METABOLITE;

ARTICLE; CONTROLLED STUDY; FEMALE; FETUS HYPOXIA; HUMAN; HUMAN TISSUE; PREECLAMPSIA; PRIORITY JOURNAL; RADIOIMMUNOASSAY; STEROIDOGENESIS;

17-ALPHA-HYDROXYPROGESTERONE; CARDENOLIDES; FEMALE; HUMANS; IMMUNOGLOBULIN FAB FRAGMENTS; KETOCONAZOLE; PLACENTA; PRE-ECLAMPSIA; PREGNANCY; RADIOIMMUNOASSAY; SAPONINS; STATISTICS, NONPARAMETRIC;

EID: 84859901549     PISSN: 19337191     EISSN: 19337205     Source Type: Journal    
DOI: 10.1177/1933719111424441     Document Type: Article

References (36)

1. Roberts JM. Preeclampsia: what we know and what we do not know. Semin Perinatal. 2000;24(1):24-28. (Pubitemid 30115266)
2. Roberts JM, Taylor RN, Musci TJ, Rodgers GM, Hubel CA, Mclaughlin MK. Preeclampsia: an endothelial cell disorder. Am J Obstet Gynecol. 1989; 161(5):1200-1204. (Pubitemid 20007682)
3. Zavalza-Gomez AB. Obesity and oxidative stress: a direct link to preeclampsia? Arch Gynecol Obstet. 2011;283:415-422.
4. Ness RB, Sibai BM. Shared and disparate components of the pathophysiologies of fetal growth restriction and preeclampsia. Am J Obstet Gynecol. 2006;195:40-49. (Pubitemid 43927490)
5. LaMarca BD, Ryan MJ, Gilbert JS, Murphy SR, Granger JP. Inflammatory cytokines in the pathophysiology of hypertension during preeclampsia. Current Hypertension Reports. 2007;9(6):480-485.
6. Sankaralingam S, Arenas IA, Lalu MM, Davidge ST. Preeclampsia: current understanding of the molecular basis of vascular dysfunction. Expert Rev in Mol Med. 2006;8:1-20.
7. Granger JP, Alexander BT, Llinas MT, Bennett WA, Khalil RA. Pathophysiology of preeclampsia: linking placental ischemia/hypoxia with microvascular dysfunction. Microcirculation. 2002;9(3):147-160. (Pubitemid 135685559)
8. Soleymanlou N, Jurisica I, Nevo O, Ietta F, Zhang X, Zamudio S. Molecular evidence of placental hypoxia in preeclampsia. J Clin Endocrinol Metab. 2005;90(7):4299-4308. (Pubitemid 41058212)
9. Graves SW, Williams GH. An endogenous ouabain-like factor associated with hypertensive pregnancies. J Clin Endocrinol Metab. 1984;59:1070-1074. (Pubitemid 15223339)
10. Valdes R Jr, Graves SW, Knight AB, Craig HR. Endogenous digoxin-immunoactivity is elevated in hypertensive pregnancy. Prog Clin Biol Res. 1985;192:229-232.
11. Graves SW. The possible role of digitalis-like factors in pregnancy-induced hypertension. Hypertens. 1987;10(S Pt 2):I-84-6.
12. Graves SW, Lincoln K, Cook SL, Seely EW. Digitalis-like factor and digoxin-like immunoreactive factor in diabetic women with preeclampsia, transient hypertension of pregnancy, and normotensive pregnancy. Am J Hypertens. 1995;8:5-11.
13. Hamlyn JM, Blaustein MP, Bova S, DuCharme DW, Harris DW, Mandel F, Mathews WR, Ludens JH. Identification and characterization of a ouabain-like compound from human plasma. Proc Natl Acad Sci USA. 1991;88:6259-6263. (Pubitemid 21914926)
14. Goto A, Yamada K. Purification of endogenous digitalis-like factors from normal human urine. Clin Exp Hypertens. 1998;20:551-556. (Pubitemid 28319527)
15. Glatter KA, Graves SW, Hollenberg NK, Soszynski PA, Tao QF, Frem GJ, Williams GH, Lazarus JM. Sustained volume expansion and [Na, K]ATPase inhibition in chronic renal failure. Am J Hypertens, 1994;7:1016-1025. (Pubitemid 24372799)
16. Krep HH, Price DA, Soszynski P, Tao Q-F, Graves SW, Hollenberg NK. Volume sensitive hypertension and the digoxin-like factor: reversal by an Fab directed against digoxin in DOCA: salt hypertensive rats. Am J Hypertens. 1995;8:921-927.
17. Krep HH, Graves SW, Price DA, Lazarus M, Ensign A, Soszynski PA, Hollenberg NK. Reversal of sodium pump inhibitor induced vascular smooth muscle contraction with Digibind: stoichiometry and its implications. Am J Hypertens. 1995;9:39-46.
18. Smith TW, Butler VP Jr, Haber E, Fozzard H, Marcus FI, Bremner WF, Schulman IC, Phillips A. Treatment of life-threatening digitalis intoxication with digoxin-specific Fab antibody fragments: experience in 26 cases. N Engl JMed. 1982;307:1357-1362. (Pubitemid 13233011)
19. Adair CD, Buckalew VM, Graves SW, Lam GK, Johnson DD, Saade G, Lewis DF, Robinson C, Danoff TM, Chauhan N, Hopoate-Sitake M, Porter KB, Humphrey RG, Trofatter KF, Amon E, Ward S, Kennedy L, Mason L, Johnston JA. Digoxin immune Fab treatment for severe preeclampsia. Amer J Perinatol. 2010;27:655-662.
20. Loose DS, Kan PB, Hirst MA, Marcus RA, Feldman D. Ketoconazole blocks adrenal steroidogenesis by inhibiting cytochrome P-450 dependent enzymes. J. Clin. Invest. 1983;71:1495-1499. (Pubitemid 13098940)
21. Miossec P, Archambeaud-Mouveroux F, Teissier MP. Inhibition of steroidogenesis by ketoconazole. Therapeutic uses. Ann Endocrinol (Paris). 1997:58:494-502. (Pubitemid 28099967)
22. Kraemer FB, Spilman SD. Effect of ketoconazole on cholesterol synthesis. J Pharmacol Exp Ther. 1986;238:905-911.
23. Kempen HJ, Van son K, Cohen LH, Griffioen M. Effect of ketoconazole on cholesterol synthesis and on HMG-CoA reductase and LDL-receptor activities in Hep G2 cells. Biochem Pharmacol. 1987;36:1245-1249. (Pubitemid 17083179)
24. Shibata Y, Takahashi H, Chiba M, Ishii Y. A novel approach to the prediction of drug-drug interactions in humans based on the serum incubation method. Drug Metab Pharmacokinet. 2008;23:328-339.
25. Levy MJ, Smotrich DB, Widra EA, Sagoskin AW, Murray DL, Hall JL. The predictive value of serum progesterone and 17-OH progesterone levels on in vitro fertilization outcome. Amer Fertility Soc. 1995;12:161-166.
26. Li H, Gu B, Zhang Y, Lewis DF, Wang Y. Hypoxia-induced increase in soluble Flt-1 production correlates with enhanced oxidative stress in trophoblast cells from the human placenta. Placenta. 2005;26:210-217. (Pubitemid 40247009)
27. + uptake caused by endogenous sodium pump inhibitors present in serum and placenta of women with preeclampsia. Reproductive Sci. 2011;18:190-199.
28. Diamandis EP, Papanastaslou-Diamandi A, Soldin SJ. Digoxin immunoreactivity in cord and maternal serum and placental extracts. Partial characterization of immunoreactive substances by high-performance liquid chromatography and inhibition of Na+, K+-ATPase. Clin Biochem. 1985;18:48-55. (Pubitemid 15009627)
29. Morris JF, Poston L, Wolfe CD, Hilton PJ. A comparison of endogenous digoxin-like immunoactivity and sodium transport inhibitory activity in umbilical arterial and venous serum. Clin Sci (Lond). 1988;75:577-579. (Pubitemid 19015436)
30. Hilton PJ, White RW, Lord GA, Garner GV, Gordon DB, Hilton MJ, Forni LG, McKinnon W, Ismail RMD, Keenan M, Jones K, Morden WE. An inhibitor of the sodium pump obtained from human placenta. Lancet. 1996;348:303-305. (Pubitemid 26254631)
31. Gao S, Chen Z, Xu Y. The source of endogenous digitalis-like substance in normal pregnancy. Zhonghua Fu Chan Ke Za Zhi. 1998;33:539-541.
32. Fedorova OV, Tapilskaya NI, Bzhelyansky AM, Frolova EV, Nikitina ER, Reznik VA, Kashkin VA, Bagrov AY. Interaction of Digibind with endogenous cardiotonic steroids from preeclamptic placentae. J Hypertens. 2010;28:361-366.
33. Ugele B, Simon S. Uptake of dehydroepiandrosterone-3sulfate by isolated trophoblasts from human term placenta, JEG-3, BeWo, Jar, BHK cells and BHK cells transfected with human sterylsulfatase-cDNA. J Steroid Biochem Mol Biol. 1999;71:203-211. (Pubitemid 30125683)
34. Fang S, Shoko H, Yukako O, Sakiko H, Kyoko T, Yasuko Y, Sadako T, Shosuke K. Evaluation of oxidative stress based on lipid hydroperoxide, vitamin C and vitamin E during apoptosis and necrosis caused by thioacetamide in rat liver. BBA-Molec Basis Disease. 2000;1500:181-185.
35. Rabe T, Brandstetter K, Kellermann J, Runnebaum B. Partial characterization of placental 3 beta-hydroxysteroid dehydrogenase (EC1.1.1.145), delta 4-5 isomerase (EC 5.3.3.1)in human term placenta. J Steroid Biochem. 1982;17:427-433. (Pubitemid 13243687)
36. Powell WA, Challis JR, Influence of 20 alpha-dihydropro-gesterone on progesterone output by human chorion explants. Gynecol Obstet Invest. 1986;22:73-78. (Pubitemid 16054812)